EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Understanding Lung Deposition of Alpha-1 Antitrypsin in Acute Experimental Mouse Lung Injury Model Using Fluorescence Microscopy

Mengmeng Wang iD, Yutian Zhan, Jianqing Chen, Haojing Rong, Shawn P O'Neil, Brahma Ghosh, Vuong Nguyen, Jane Owens iD, Xianfeng Li, Denise M O'Hara iD

International Journal of Molecular Imaging · 06.12.2016 · 2016 · 1-11

DOI: 10.1155/2016/5768312 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Imaging, erschienen am 06.12.2016. Verfasst von Mengmeng Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Andover, MA, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human plasma-derived α 1-antitrypsin (AAT) delivered by intravenous infusion is used as augmentation therapy in patients with emphysema who have a genetic mutation resulting in deficiency of AAT. Inhalation is an alternative route of administration that can potentially increase the efficacy and convenience of treatment. This study was conducted to determine whether delivery to the lungs, initially via the intratracheal (IT) route of administration, would deliver efficacious levels of a recombinant AAT (rAAT) to the site of action in the lungs in mice. 125 I-radiolabeled rAAT, fluorophore-conjugated rAAT (rAAT-Alexa488), and NE680 (neutrophil elastase 680, a silent fluorescent substrate of neutrophil elastase which fluoresces in the near-infrared range upon activation by neutrophil elastase) were used to characterize the pharmacokinetics and tissue distribution profile, distribution of rAAT within the lung, and efficacy of rAAT to inhibit neutrophil elastase at the site of action, respectively. The study has demonstrated that rAAT was able to gain access to locations where neutrophil elastase was localized. The histochemical quantification of rAAT activity relative to dose at the site of action provided here will improve confidence in predicting the human dose via the inhalation route.

Autor:innen und Institutionen

  • Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc., Andover, MA, USA.
  • Drug Safety R&D, Pfizer Inc., Andover, MA, USA.
  • Clinical R&D, Pfizer Inc., Cambridge, MA, USA.
  • Molecular Imaging Laboratory, Pfizer Inc., Andover, MA, USA.
  • Rare Disease RU, Pfizer Inc., Cambridge, MA, USA.

ORCID-Profile: Mengmeng Wang, Jane Owens, Denise M O'Hara

Zitieren

APA

Wang, M., Zhan, Y., Chen, J., Rong, H., O'Neil, S. P., Ghosh, B., Nguyen, V., Owens, J., Li, X., & O'Hara, D. M. (2016). Understanding Lung Deposition of Alpha-1 Antitrypsin in Acute Experimental Mouse Lung Injury Model Using Fluorescence Microscopy. International Journal of Molecular Imaging, 2016, 1-11. https://doi.org/10.1155/2016/5768312

Vancouver

Wang M, Zhan Y, Chen J, Rong H, O'Neil SP, Ghosh B, et al. Understanding Lung Deposition of Alpha-1 Antitrypsin in Acute Experimental Mouse Lung Injury Model Using Fluorescence Microscopy. International Journal of Molecular Imaging. 2016;2016:1-11. doi:10.1155/2016/5768312

BibTeX
@article{Wang2016,
  author = {Wang, Mengmeng and Zhan, Yutian and Chen, Jianqing and Rong, Haojing and O'Neil, Shawn P and Ghosh, Brahma and Nguyen, Vuong and Owens, Jane and Li, Xianfeng and O'Hara, Denise M},
  title = {Understanding Lung Deposition of Alpha-1 Antitrypsin in Acute Experimental Mouse Lung Injury Model Using Fluorescence Microscopy},
  journal = {International Journal of Molecular Imaging},
  year = {2016},
  volume = {2016},
  pages = {1--11},
  doi = {10.1155/2016/5768312}
}
Kostenlos starten →